Association between transforming growth factor β1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects

Molecular and Cellular Biochemistry

Volumn 335, Issue 1-2, 2010, Pages 13-17

  Xu, Hai Ying ^a   Hou, Xu Wei ^a   Wang, Li Fang ^b   Wang, Ning Fu ^a   Xu, Jian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Essential hypertensive; Hypertrophy; Polymorphism; Transforming growth factor 1

Indexed keywords

C REACTIVE PROTEIN; GENOMIC DNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CHINESE; CODON; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SMOKING; SYSTOLIC BLOOD PRESSURE;

ARGININE; ASIAN CONTINENTAL ANCESTRY GROUP; CODON; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LEUCINE; MUTATION; POLYMORPHISM, GENETIC; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 75949128360     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0235-x     Document Type: Article

References (27)

1. MJ Koren RJ Ulin AT Koren, et al. 2002 Left ventricular mass change during treatment and outcome in patients with essential hypertension Am J Hypertens 15 12 1021 1028 10.1016/S0895-7061(02)03061-3 12460696 (Pubitemid 35397534)
2. P Verdecchia G Schillaci C Borgioni, et al. 1998 Prognostic significance of serial changes in left ventricular mass in essential hypertension Circulation 97 1 48 54 1:STN:280:DyaK1c7gtlKlug%3D%3D 9443431 (Pubitemid 28036154)
3. P Verdecchia C Porcellati 1993 Defining normal ambulatory blood pressure in relation to target organ damage and prognosis Am J Hypertens 6 207S 210S 1:STN:280:DyaK3szkvFCktw%3D%3D 8347320
4. D Levy RJ Garrison DD Savage, et al. 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1561 1566 1:STN:280:DyaK3c3ksFSmug%3D%3D 2139921
5. Meijs MF, de Windt LJ, de Jonge N, Doevendans PA et al (2007) Left ventricular hypertrophy: a shift in paradigm. Curr Med Chem 14(2):157-171
6. RE Schmieder 2005 The role of non-haemodynamic factors of the genesis of LVH Nephrol Dial Transplant 20 12 2610 2612 10.1093/ndt/gfi190 16221701 (Pubitemid 41672256)
7. DK Arnett L de las Fuentes U Broeckel 2004 Genes for left ventricular hypertrophy Curr Hypertens Rep 6 1 36 41 10.1007/s11906-004-0009-5 14972088
8. CF Deschepper I Boutin-Ganache A Zahabi, et al. 2000 In search of cardiovascular candidate genes: interactions between phenotypes and genotypes Hypertension 39 332 336 10.1161/hy0202.102787
9. RA Ignotz J Massague 1986 Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix J Biol Chem 261 4337 4345 1:CAS:528:DyaL28Xhs1amur4%3D 3456347
10. ZY He B Feng SL Yang, et al. 2005 Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy Acta Cardiol 60 21 25 10.2143/AC.60.1.2005044 15779847 (Pubitemid 40824314)
11. A Agrotis N Kalinina A Bobik 2005 Transforming growth factor-beta, cell signaling and cardiovascular disorders Curr Vasc Pharmacol 3 55 61 10.2174/1570161052773951 1:CAS:528:DC%2BD2MXhvFOhsg%3D%3D 15638782 (Pubitemid 40089527)
12. F Andreotti I Porto F Crea A Maseri 2002 Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies Heart 87 107 112 10.1136/heart.87.2.107 1:CAS:528:DC%2BD38XlvFOluro%3D 11796541
13. S Nikol JM Isner JG Pickering, et al. 1992 Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions J Clin Invest 90 1582 1592 10.1172/JCI116027 1:STN:280:DyaK3s%2Fhs1yqsA%3D%3D 1328302
14. PJ Lijnen VV Petrov RH Fagard 2000 Induction of cardiac fibrosis by transforming growth factor-beta(1) Mol Genet Metab 71 1-2 418 435 10.1006/mgme.2000.3032 1:CAS:528:DC%2BD3cXms1yjsbg%3D 11001836 (Pubitemid 30749566)
15. MP Sie FU Mattace-Raso AG Uitterlinden, et al. 2007 TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study J Hum Hypertens 21 6 431 437 1:CAS:528:DC%2BD2sXltlaqu74%3D 17361195
16. Crobu F, Palumbo L, Franco E, et al (2008) Role of TGF-beta1 haplotypes in the occurrence of myocardial infarction in young Italian patients. BMC Med Genet 9:13
17. MP Sie AG Uitterlinden MJ Bos, et al. 2006 TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study Stroke 37 11 2667 2671 10.1161/01.STR.0000244779.30070.1a 1:CAS:528:DC%2BD28XhtVyns7bM 17023672 (Pubitemid 44922523)
18. W Koch P Hoppmann JC Mueller, et al. 2006 Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease Arterioscler Thromb Vasc Biol 26 5 1114 1119 10.1161/01.ATV.0000217747.66517.11 1:CAS:528: DC%2BD28XjsVersb8%3D 16543493 (Pubitemid 43732120)
19. F Cambien S Ricard A Troesch, et al. 1996 Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study Hypertension 28 5 881 887 1:CAS:528:DyaK28XmvVKltb4%3D 8901839
20. H Xue S Wang H Wang, et al. 2008 Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension Clin Sci 114 2 131 137 10.1042/CS20070109 1:CAS:528:DC%2BD2sXhsVagtrvN 17672826
21. M Rao D Guo BL Jaber, et al. 2004 Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients Kidney Int 66 1 419 427 10.1111/j.1523-1755.2004.00748.x 1:CAS:528:DC%2BD2cXmtVSitL8%3D 15200451 (Pubitemid 38870120)
22. CT Holweg CC Baan HG Niesters, et al. 2001 TGF-beta1 gene polymorphisms in patients with end-stage heart failure J Heart Lung Transplant 20 9 979 984 10.1016/S1053-2498(01)00296-0 1:STN:280:DC%2BD3MrhtVWmug%3D%3D 11557193 (Pubitemid 32824144)
23. Holweg CT, Baan CC, Balk AH et al (2001) The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 71(10):1463-1467
24. M Yokota S Ichihara TL Lin, et al. 2000 Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 24 2783 2787 1:CAS:528:DC%2BD3cXksVCgtbk%3D 10859282
25. P Hallberg J Karlsson L Lind, et al. 2004 Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment-results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Clin Cardiol 27 5 287 290 10.1002/clc.4960270510 1:STN:280:DC%2BD2c3ovVersw%3D%3D 15188945 (Pubitemid 38703080)
26. TM Aziz PS Hasleton N Yona, et al. 2001 Transforming growth factor beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation Transplant Proc 33 2334 2336 10.1016/S0041-1345(01)02013-9 1:CAS:528:DC%2BD3MXjslCjtrk%3D 11377551
27. MR Awad A El-gamel P Hasleton, et al. 1998 Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation Transplantation 66 1014 1020 10.1097/00007890-199810270-00009 1:CAS:528:DyaK1cXnsFelurw%3D 9808485 (Pubitemid 28513380)